Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening
BackgroundTandem mass spectrometry (MS/MS) is a crucial technique for detecting inborn errors of metabolism (IEM) in newborns. However, the high false positive rate poses challenges in diagnosing specific types of diseases. Therefore, this study aimed to evaluate the role of targeted next-generation...
Saved in:
| Main Authors: | Guihua Lai, Qiying Gu, Zhiyong Lai, Haijun Chen, Xiangwen Tu, Junkun Chen, Jungao Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2024.1461141/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanded newborn screening for inborn errors of metabolism and genetic variants in Xinjiang, China
by: Huiwen Zhang, et al.
Published: (2025-07-01) -
Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening
by: Céline Renoux, et al.
Published: (2024-11-01) -
Spectrum analysis of inborn errors of metabolism for expanded newborn screening in Xinjiang, China
by: Jingying Zhu, et al.
Published: (2024-12-01) -
Propionyl Carnitine Metabolic Profile: Optimizing the Newborn Screening Strategy Through Customized Cut-Offs
by: Maria Lucia Tommolini, et al.
Published: (2025-05-01) -
Development, Validation, and Application of the Paya Hamsan Technologies Underivatized Newborn Screening Assay (PHUNSA) for Inborn Metabolic Disorders in Dried Blood Spot Samples from Iranian Infants
by: Azam Khodadadi, et al.
Published: (2025-01-01)